Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease

Annals of Hematology

Volumn 84, Issue 9, 2005, Pages 578-583

  Ren, Hongmei ^a   Okpala, Iheanyi ^b   Ghebremeskel, Kebreab ^a   Ugochukwu, Cynthia C ^b   Ibegbulam, Obike ^c   Crawford, Michael ^a  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Lipids; Mononuclear cells; Platelets; Sickle cell disease

Indexed keywords

ARACHIDONIC ACID; BETA2 INTEGRIN; CELL ADHESION MOLECULE; DOCOSAHEXAENOIC ACID; FATTY ACID; GLYCEROPHOSPHORYLCHOLINE; ICOSAPENTAENOIC ACID; L SELECTIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CELL; CELL COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; HOMOZYGOSITY; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LIPID COMPOSITION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX RATIO; SICKLE CELL ANEMIA; STEADY STATE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANEMIA, SICKLE CELL; ARACHIDONIC ACID; BLOOD CELLS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL ADHESION; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS; HOMOZYGOTE; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS;

EID: 23944472441     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1023-7     Document Type: Article

References (37)

1. Anel A, Naval J, Gonzalez B, Uriel J, Pineiro A (1990) Fatty acid metabolism in human lymphocytes: II. Activation of fatty acid desaturase-elongase systems during blastic transformation. Biochim Biophys Acta 1044:332-339
2. Anyaegbu CC, Okpala IE, Aken'Ova AY, Salimonu LS (1998) Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA). Eur J Haematol 60:267-268
3. Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM (2000) Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96:2451-2459 1:CAS:528:DC%2BD3cXntVaru70%3D
4. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM (1993) Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vaso-occlusion. Blood 81:2137-2143
5. Calder PC (2003) N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 38:343-352
6. Chiu D, Lubin B, Roelofsen B, Van Deenen LL (1981) Sickled erythrocytes accelerate clotting in vitro: An effect of abnormal lipid asymmetry. Blood 58:398-401
7. Folch J, Lees M, Slone-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226:497-509 1:STN:280:CyiD2srktVE%3D
8. Frenette PS (2002) Sickle cell vaso-occlusion: Multistep and multicellular paradigm. Curr Opin Hematol 9:101-106 10.1097/ 00062752-200203000-00003
9. Guyer DA, Moore KL, Lynam EB, Schammel CM, Rogelj S, McEver RP, Sklar LA (1996) P-selectin glycoprotein ligand (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood 88:2415-2421
10. Hughes DA, Pinder AC, Piper Z, Johnson IT, Lund EK (1996) Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 63:267-272
11. Kaul DK, Fabry ME, Nagel RL (1989) Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci U S A 86:3356-3360
12. Kaul DK, Fabry ME, Nagel RL (1996) The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev 10:29-44
13. Khalfoun B, Thibault G, Bardos P, Lebranchu Y (1996) Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion. Transplantation 62:1649-1657
14. Kurantsin-Mills J, Ibe BO, Natta CL, Raj JU, Siegel RS, Lessin LS (1994) Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation. Br J Haematol 87:580-585
15. Laposata M, Reich EL, Majerus PW (1985) Arachidonoyl-CoA synthetase. Separation from nonspecific acyl-CoA synthetase and distribution in various cells and tissues. J Biol Chem 260:11016-11020
16. Mills DE, Galey WR, Dixon H (1993) Effects of dietary fatty-acid supplementation on fatty-acid composition and deformability of young and old erythrocytes. Biochim Biophys Acta 1149:313-318
17. Needleman SW, Spector AA, Hoak JC (1982) Enrichment of human platelet phospholipids with linoleic acid diminishes thromboxane release. Prostaglandins 24:607-622
18. Nishiyama A, Cavaglieri CR, Curi R, Calder PC (2000) Arachidonic acid-containing phosphatidylcholine inhibits lymphocyte proliferation and decreases interleukin-2 and interferon-gamma production from concanavalin A-stimulated rat lymphocytes. Biochim Biophys Acta 1487:50-60
19. 2 integrin and L-selectin by leukocytes of patients with severe manifestations of sickle cell disease Blood 100 [Suppl] 11a
20. Okpala IE, Daniel Y, Haynes R, Odoemene D, Goldman JM (2002) Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. Eur J Haematol 69:135-144
21. IE Okpala 2004 Epidemiology, genetics and pathophysiology of sickle cell disease In: IE Okpala (ed.) Practical management of haemoglobinopathies Blackwell Publishing Oxford 20-25
22. Okpala IE (2004) The intriguing contribution of white blood cells to sickle cell disease- a red cell disorder. Blood Rev 18:65-73
23. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639-1644 10.1056/ NEJM199406093302303
24. Powars DR (2000) Management of cerebral vasculopathy in children with sickle cell anaemia. Br J Haematol 108:666-678
25. Rodgers GP (1997) Overview of pathophysiology and rationale for treatment of sickle cell anemia. Semin Hematol 34:2-7
26. Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ (1985) Increased adherence of sickled erythrocytes and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 75:1965-1972
27. Setty BN, Chen D, O'Neal P, Littrell JB, Grossman MH, Stuart MJ (1998) Eicosanoids in sickle cell disease: Potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion. J Lab Clin Med 131:344-353
28. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301-314 10.1016/ 0092-8674(94)90337-9
29. Steinberg MH (1998) Pathophysiology of sickle cell disease. Baillieres Clin Haematol 11:163-184
30. Steinberg MH, Rodgers GP (2001) Pathophysiology of sickle cell disease: role of cellular and genetic modifiers. Semin Hematol 38:299-306
31. Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BA, Kuypers FA (1996) Phospholipase A2 levels in acute chest syndrome of sickle cell anaemia. Blood 87:2573-2578
32. Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK (1998) Interaction of sickle cell erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 92:3924-3935 1:CAS:528:DyaK1cXnsVKltL0%3D
33. Tan P, Luscinskas FW, Homer-Vanniasinkams S (1999) Cellular and molecular mechanisms of inflammation and thrombosis. Eur J Vasc Endovasc Surg 17:373-389
34. Tomer A, Kasey S, Connor WE, Clark S, Harker LA, Eckman JR (2001) Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost 85:966-974
35. Wun T, Cordoba M, Rangaswami A, Cheung AW, Paglieroni T (2002) Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. Clin Lab Haematol 24:81-88
36. Yang J, Furie BC, Furie B (1999) The biology of P-selectin glycoprotein ligand-1: Its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 81:1-7
37. Yli-Jama P, Seljeflot I, Meyer HE, Hjerkinn EM, Arnesen H, Pedersen JI (2002) Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction. Atherosclerosis 164:275-281